Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting
Go back to Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting| ALKERMES (NASDAQ: ALKS) | Delayed: 46.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.02 | 52 Week High | $80.71 | |||
| Open | $46.02 | 52 Week Low | $27.14 | |||
| Day High | $46.02 | P/E | 354.00 | |||
| Day Low | $46.02 | EPS | $0.13 | |||
| Volume | 958 | |||||
